Literature DB >> 17276463

Role of non-neuronal cholinergic system in breast cancer progression.

Alejandro J Español1, Eulalia de la Torre, Gabriel L Fiszman, María E Sales.   

Abstract

We have previously reported the expression of functional muscarinic acetylcholine receptors (mAChR) in two different murine mammary adenocarcinoma cell lines LM2 and LM3. Activation of mAChR with carbachol (CARB) increased proliferation in both tumor cell lines in a concentration-dependent manner. In LM3 cells CARB promoted proliferation via M(3) receptor activation by inositol 1,4,5-triphosphate and nitric oxide (NO) production. CARB-induced LM2 cells proliferation needed both M(2) and M(1) receptor activation increasing prostaglandin E(2) liberation and arginase catabolism respectively. Our present results indicate that CARB stimulates LM2 and LM3-induced angiogenesis and tumor growth. This activation follows different patterns. In LM2 tumor, M(1) and M(2) receptors activation stimulates neovascularization by arginase II and cyclooxygenase-2 (COX-2)-derived products while M(1) and M(3) receptors mediate CARB-induced tumor growth by the same effector enzymes. In LM3 tumor, we observe that M(1) and M(2) receptors are involved in agonist-stimulated angiogenesis by COX and NOS1-derived products while tumor growth is stimulated by M(3) and M(2) receptors activation and COX-2-derived prostanoids. Taken together these data present, at least in part, a picture of the regulation that different mAChR subtypes activation exerts on angiogenesis and growth of two different murine mammary adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17276463     DOI: 10.1016/j.lfs.2006.12.017

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  15 in total

Review 1.  Muscarinic receptors and ligands in cancer.

Authors:  Nirish Shah; Sandeep Khurana; Kunrong Cheng; Jean-Pierre Raufman
Journal:  Am J Physiol Cell Physiol       Date:  2008-11-26       Impact factor: 4.249

Review 2.  GPCRs and cancer.

Authors:  Rosamaria Lappano; Marcello Maggiolini
Journal:  Acta Pharmacol Sin       Date:  2012-01-23       Impact factor: 6.150

3.  Treatment with LPS plus INF-γ induces the expression and function of muscarinic acetylcholine receptors, modulating NIH3T3 cell proliferation: participation of NOS and COX.

Authors:  A J Español; M O Maddaleno; M G Lombardi; M Cella; P Martínez Pulido; M E Sales
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

4.  High expression of M3 muscarinic acetylcholine receptor is a novel biomarker of poor prognostic in patients with non-small cell lung cancer.

Authors:  Jun Wu; Jinxu Zhou; Lei Yao; Yaoguo Lang; Yingnan Liang; Lantao Chen; Jinfeng Zhang; Fengjiao Wang; Yanbo Wang; He Chen; Jianqun Ma
Journal:  Tumour Biol       Date:  2013-07-10

Review 5.  Muscarinic receptor agonists and antagonists: effects on cancer.

Authors:  Eliot R Spindel
Journal:  Handb Exp Pharmacol       Date:  2012

6.  Autophagy Induced by Muscarinic Acetylcholine Receptor 1 Mediates Migration and Invasion Targeting Atg5 via AMPK/mTOR Pathway in Prostate Cancer.

Authors:  Qianhui Wang; Jinying Chen; Mi Zhang; Hong Wang; Yan Zeng; Yanping Huang; Chen Xu
Journal:  J Oncol       Date:  2022-06-09       Impact factor: 4.501

7.  Epigenetic modulation of the muscarinic type 3 receptor in salivary epithelial cells.

Authors:  Yong-Hwan Shin; Meihong Jin; Sung-Min Hwang; Seul-Ki Choi; Eun Namkoong; Minkyoung Kim; Moon-Yong Park; Se-Young Choi; Jong-Ho Lee; Kyungpyo Park
Journal:  Lab Invest       Date:  2014-12-08       Impact factor: 5.662

8.  Immunoglobulin g from breast cancer patients regulates MCF-7 cells migration and MMP-9 activity by stimulating muscarinic acetylcholine receptors.

Authors:  Laura T Pelegrina; María Gabriela Lombardi; Gabriel L Fiszman; María E Azar; Carlos Cresta Morgado; María E Sales
Journal:  J Clin Immunol       Date:  2012-09-25       Impact factor: 8.317

9.  Nitric oxide synthase 1 and cyclooxygenase-2 enzymes are targets of muscarinic activation in normal and inflamed NIH3T3 cells.

Authors:  A J Español; N Goren; M L Ribeiro; María Elena Sales
Journal:  Inflamm Res       Date:  2009-10-13       Impact factor: 4.575

10.  Novel information on the non-neuronal cholinergic system in orthopedics provides new possible treatment strategies for inflammatory and degenerative diseases.

Authors:  Sture Forsgren; Håkan Alfredson; Dennis Bjur; Solbritt Rantapää-Dahlqvist; Orjan Norrgård; Tore Dalén; Patrik Danielson
Journal:  Orthop Rev (Pavia)       Date:  2009-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.